SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

BRIEF-Pliant Therapeutics Inc - QTRLY Loss Per Share $0.64

05/10/2021 18:19
BRIEF-Pliant Therapeutics Inc - QTRLY Loss Per Share $0.64

Pliant Therapeutics Inc PLRX.O:

  • PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS

  • PLN-74809 PHASE 2A PET IMAGING TRIAL CONTINUES TO ENROLL WITH PRELIMINARY DATA EXPECTED FIRST HALF OF 2021

  • BELIEVES IT HAS SUFFICIENT FUNDS TO MEET ITS OPERATING AND CAPITAL REQUIREMENTS INTO 2023

  • QTRLY LOSS PER SHARE $0.64

  • Q1 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA

Source text for Eikon: ID:nGNX9n7C9k

Further company coverage: PLRX.O